PAVmed (PAVM) Research Hub

PAVmed (PAVM) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 2.26 USD (+4.15%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.13, market cap 0.00B. This hub links to the full technical, earnings and options research available for PAVM.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNASDAQ, US
Last close2.26 USD (+4.15%)
52-week range1.84 USD – 6.65 USD
Trend regimeRange
14-day RSI35.3 (Bearish)
Trailing P/E-0.13
Market cap0.00B
Dividend yield0.00%
Next earnings2026-08-13

Available research for PAVM

Earnings

PAVM earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -0.13. Updated 2026-07-23.

Options: Covered Call

Covered Call on PAVM: how it works, illustrative setup around the real 2.26 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on PAVM: how it works, illustrative setup around the real 2.26 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on PAVM: how it works, illustrative setup around the real 2.26 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

PAVM technical analysis: range, last 2.26 USD, RSI 35.3, 52w range 1.84 USD–6.65 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is PAVM in?

PAVmed (PAVM) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.

Is PAVM in an uptrend or downtrend?

As of 2026-10-26, PAVM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is PAVM's trailing P/E ratio?

PAVM's trailing P/E is -0.13, with a market cap of 0.00B. See the earnings research page for full valuation detail.

When does PAVM next report earnings?

PAVM is next scheduled to report earnings on 2026-08-13.